Evaluation of an Innovative Point-of-Care Rapid Diagnostic Test for the Identification of Imported Malaria Parasites in China
Open Access
- 28 May 2023
- journal article
- research article
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 8 (6), 296
- https://doi.org/10.3390/tropicalmed8060296
Abstract
Background: China was certified malaria-free by the World Health Organization on 30 June 2021. However, due to imported malaria, maintaining a malaria-free status in China is an ongoing challenge. There are critical gaps in the detection of imported malaria through the currently available tools, especially for non-falciparum malaria. In the study, a novel point-of-care Rapid Diagnostic Test designed for the detection of imported malaria infections was evaluated in the field. Methods: Suspected imported malaria cases reported from Guangxi and Anhui Provinces of China during 2018–2019 were enrolled to evaluate the novel RDTs. Diagnostic performance of the novel RDTs was evaluated based on its sensitivity, specificity, positive and negative predictive values, and Cohen’s kappa coefficient, using polymerase chain reaction as the gold standard. The Additive and absolute Net Reclassification Index were calculated to compare the diagnostic performance between the novel RDTs and Wondfo RDTs (control group). Results: A total of 602 samples were tested using the novel RDTs. Compared to the results of PCR, the novel RDTs presented sensitivity, specificity, PPV, NPV, and diagnostic accuracy rates of 78.37%, 95.05%, 94.70%, 79.59%, and 86.21%, respectively. Among the positive samples, the novel RDTs found 87.01%, 71.31%, 81.82%, and 61.54% of P. falciparum, P. ovale, P. vivax, and P. malariae, respectively. The ability to detect non-falciparum malaria did not differ significantly between the novel and Wondfo RDTs (control group). However, Wondfo RDTs can detect more P. falciparum cases than the novel RDTs (96.10% vs. 87.01%, p < 0.001). After the introduction of the novel RDTs, the value of the additive and absolute Net Reclassification Index is 1.83% and 1.33%, respectively. Conclusions: The novel RDTs demonstrated the ability to distinguish P. ovale and P. malariae from P. vivax which may help to improve the malaria post-elimination surveillance tools in China.Keywords
Funding Information
- Study on the prevalence of important infectious diseases in Africa (2016 ZX10004222)
- China–Africa cooperation project on malaria control (2020-C4-0002-3)
- Chinese Center for Tropical Diseases Research (131031104000160004)
- UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (2021/1104003–0)
This publication has 27 references indexed in Scilit:
- Transmission Risk from ImportedPlasmodium vivaxMalaria in the China–Myanmar Border RegionEmerging Infectious Diseases, 2015
- Imported malaria among people who travel to visit friends and relatives: is current UK policy effective or does it need a strategic change?Malaria Journal, 2015
- Use of the Rapid BinaxNOW Malaria Test in a 24-Hour Laboratory Associated with Accurate Detection and Decreased Malaria Testing Turnaround Times in a Pediatric Setting Where Malaria Is Not EndemicJournal of Clinical Microbiology, 2013
- Preferential Invasion by Plasmodium Merozoites and the Self-Regulation of Parasite BurdenPLOS ONE, 2013
- Opportunities for improving pLDH-based malaria diagnostic testsMalaria Journal, 2011
- Plasmodium ovale curtisi and Plasmodium ovale wallikeri circulate simultaneously in African communitiesInternational Journal for Parasitology, 2011
- Emergence and control of infectious diseases in ChinaThe Lancet, 2008
- Plasmodium malariae and Plasmodium ovale – the ‘bashful’ malaria parasitesTrends in Parasitology, 2007
- Ensuring quality and access for malaria diagnosis: how can it be achieved?Nature Reviews Microbiology, 2006
- Development of a Real-Time PCR Assay for Detection of Plasmodium falciparum , Plasmodium vivax , and Plasmodium ovale for Routine Clinical DiagnosisJournal of Clinical Microbiology, 2004